Amy Kang

1.0k total citations
29 papers, 628 citations indexed

About

Amy Kang is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Amy Kang has authored 29 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Amy Kang's work include Diabetes Treatment and Management (10 papers), Dialysis and Renal Disease Management (4 papers) and Diabetes Management and Research (4 papers). Amy Kang is often cited by papers focused on Diabetes Treatment and Management (10 papers), Dialysis and Renal Disease Management (4 papers) and Diabetes Management and Research (4 papers). Amy Kang collaborates with scholars based in Australia, United States and United Kingdom. Amy Kang's co-authors include Meg Jardine, Vlado Perkovic, Anisha Tanna, Brendon L. Neuen, Charles D. Pusey, Kenneth W. Mahaffey, Nishkantha Arulkumaran, Clare Arnott, Alan Cass and Bruce Neal and has published in prestigious journals such as Diabetes Care, Diabetes and Cochrane Database of Systematic Reviews.

In The Last Decade

Amy Kang

29 papers receiving 615 citations

Peers

Countries citing papers authored by Amy Kang

Since Specialization

Citations

This map shows the geographic impact of Amy Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Kang more than expected).

Fields of papers citing papers by Amy Kang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Kang. The network helps show where Amy Kang may publish in the future.

Co-authorship network of co-authors of Amy Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Kang. A scholar is included among the top collaborators of Amy Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Kang. Amy Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial 2024 ·Diabetes Obesity and Metabolism ·(unknown), Amy Kang, Brendan Smyth, (unknown), Carol A. Pollock, Rajiv Agarwal, (unknown), David M. Charytan, Dick de Zeeuw, David C. Wheeler, Hong Zhang, Christopher P. Cannon, Vlado Perkovic, Clare Arnott, Adeera Levin, Kenneth W. Mahaffey	2
2	The sodium‐glucose cotransporter‐2 inhibitor canagliflozin does not increase risk of non‐genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double‐blind trials 2023 ·Diabetes Obesity and Metabolism ·Amy Kang, Brendan Smyth, Brendon L. Neuen, Hiddo J.L. Heerspink, Gian Luca Di Tanna, Hong Zhang, Clare Arnott, Carinna Hockham, Rajiv Agarwal, George L. Bakris, David M. Charytan, Dick de Zeeuw, Tom Greene, Adeera Levin, Carol A. Pollock, David C. Wheeler, Kenneth W. Mahaffey, Vlado Perkovic, Meg Jardine	4
3	Altered Tau Kinase Activity in rTg4510 Mice after a Single Interfaced CHIMERA Traumatic Brain Injury 2023 ·International Journal of Molecular Sciences ·Wai Hang Cheng, (unknown), Amy Kang, Jianjia Fan, Jennifer Cooper, (unknown), Carlos Barrón, Anna Wilkinson, Grace Hu, (unknown), Peter A. Cripton, David J. Vocadlo, Cheryl L. Wellington	1
4	Effect of Hemodiafiltration on the Progression of Neuropathy with Kidney Failure 2021 ·Clinical Journal of the American Society of Nephrology ·Amy Kang, Ria Arnold, Martin Gallagher, Paul Snelling, (unknown), Mangalee Fernando, Matthew C. Kiernan, (unknown), (unknown), (unknown), (unknown), Kris Rogers, Amritendu Bhattacharya, Brendan Smyth, (unknown), Carmel M. Hawley, Vlado Perkovic, Arun V. Krishnan, Meg Jardine	10
5	129-LB: Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex in the CREDENCE Trial 2021 ·Diabetes ·(unknown), Brendan Smyth, Amy Kang, (unknown), Gian Luca Di Tanna, Clare Arnott, Carol A. Pollock, Rajiv Agarwal, George L. Bakris, Christopher P. Cannon, Dick de Zeeuw, Hiddo J.L. Heerspink, Adeera Levin, Bruce Neal, David C. Wheeler, Hong Zhang, Bernard Zinman, Kenneth W. Mahaffey, Vlado Perkovic, Meg Jardine, (unknown)	1
6	Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA1c, disease duration and treatment intensity: results from the CANVAS Program 2021 ·Diabetologia ·T. Kue Young, Jingwei Li, Amy Kang, Hiddo J.L. Heerspink, Carinna Hockham, Clare Arnott, Brendon L. Neuen, Sophia Zoungas, Kenneth W. Mahaffey, Vlado Perkovic, Dick de Zeeuw, Greg Fulcher, Bruce Neal, Meg Jardine	7
7	Relationship between measured and prescribed dialysate sodium in haemodialysis: a systematic review and meta-analysis 2020 ·Nephrology Dialysis Transplantation ·Jack Kit‐Chung Ng, Brendan Smyth, Mark R. Marshall, Amy Kang, J Pintér, Abhinav Bassi, Rathika Krishnasamy, Patrick Rossignol, Michael V. Rocco, Li Zuo, Vivekanand Jha, Carmel M. Hawley, Peter G. Kerr, Gian Luca Di Tanna, Mark Woodward, (unknown)	7
8	Incidence and Associations of Chronic Kidney Disease in Community Participants With Diabetes: A 5-Year Prospective Analysis of the EXTEND45 Study 2020 ·Diabetes Care ·(unknown), Amy Kang, Carinna Hockham, T. Kue Young, Min Jun, Celine Foote, Roberto Pecoits‐Filho, Brendon L. Neuen, Kris Rogers, Carol A. Pollock, Alan Cass, David Sullivan, Germaine Wong, John Knight, David Peiris, Martin Gallagher, Meg Jardine	24
9	Risk factors for incident kidney disease in older adults: an Australian prospective population‐based study 2020 ·Internal Medicine Journal ·Amy Kang, (unknown), Carinna Hockham, Min Jun, T. Kue Young, Anish Scaria, Celine Foote, Brendon L. Neuen, Alan Cass, Carol A. Pollock, Elizabeth Comino, Thomas Lung, Roberto Pecoits‐Filho, Kris Rogers, Meg Jardine	2
10	SGLT2 inhibitors may offer benefit beyond diabetes 2020 ·Nature Reviews Nephrology ·Amy Kang, Meg Jardine	32
11	Effect of Treatment on Damage and Hospitalization in Elderly Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis 2019 ·The Journal of Rheumatology ·Maria Weiner, (unknown), Aladdin J Mohammad, Zdenka Hrušková, Anisha Tanna, P. Sharp, Amy Kang, Annette Bruchfeld, Daina Selga, (unknown), Kerstin Westman, Per Eriksson, Lorraine Harper, Charles D. Pusey, Vladimı́r Tesař, Alan D. Salama, Mårten Segelmark	9
12	Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to 23-valent pneumococcal polysaccharide in immunocompetent adults: A systematic review and meta-analysis 2019 ·Vaccine ·Nirma Khatri Vadlamudi, (unknown), (unknown), Amy Kang, Fawziah Marra	19
13	1130-P: Temporal Trends in Pharmacotherapy for Diabetes 2019 ·Diabetes ·T. Kue Young, Carinna Hockham, (unknown), Amy Kang, Min Jun, Jannah Baker, Kris Rogers, Alan Cass, Carol A. Pollock, David Sullivan, (unknown), Meg Jardine	1
14	Randomised controlled trial of the impact of haemodiafiltration on uraemic neuropathy: FINESSE study protocol 2019 ·BMJ Open ·Brendan Smyth, Arun V. Krishnan, Martin Gallagher, Matthew C. Kiernan, Paul Snelling, Carmel M. Hawley, Mangalee Fernando, (unknown), (unknown), (unknown), (unknown), Amy Kang, Vlado Perkovic, Meg Jardine	3
15	High Incidence of Arterial and Venous Thrombosis in Antineutrophil Cytoplasmic Antibody–associated Vasculitis 2018 ·The Journal of Rheumatology ·Amy Kang, Marilina Antonelou, (unknown), Anisha Tanna, Nishkantha Arulkumaran, Frederick W.K. Tam, Charles D. Pusey	31
16	WS7_1 Organ Damage and Hospitalization in Elderly Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis 2017 ·Lara D. Veeken ·Maria Weiner, (unknown), Aladdin J Mohammad, Zdenka Hrušková, Anisha Tanna, P. Sharp, Amy Kang, Annette Bruchfeld, Daina Selga, (unknown), Kerstin Westman, Per Eriksson, Lorraine Harper, Charles D. Pusey, Vladimı́r Tesař, Alan D. Salama, Mårten Segelmark	11
17	Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients 2017 ·Kidney International ·Stephen P. McAdoo, Anisha Tanna, Zdenka Hrušková, (unknown), Maria Weiner, Nishkantha Arulkumaran, Amy Kang, Veronika Satrapová, Jeremy Levy, Sophie Ohlsson, Vladimı́r Tesař, Mårten Segelmark, Charles D. Pusey	140
18	Simple prescribing errors and allergy documentation in medical hospital admissions in Australia and New Zealand 2012 ·Clinical Medicine ·Lorna Barton, (unknown), (unknown), Amy Kang, (unknown), (unknown), (unknown), Campbell Thompson, (unknown)	24
19	The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis 2012 ·BMJ ·Meg Jardine, Amy Kang, Sophia Zoungas, Sankar D. Navaneethan, Toshiharu Ninomiya, Sagar U. Nigwekar, Martin Gallagher, Alan Cass, Giovanni FM Strippoli, Vlado Perkovic	74
20	3 Case Reports of Cheongungkyeoji-tang for Post-stroke Patients with Shoulder Pain 2006 ·The Journal of Internal Korean Medicine ·Won‐Yong Shin, (unknown), (unknown), Amy Kang, (unknown), (unknown), (unknown), Chang-ho Han, (unknown), (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact